| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |